ad image
Impact of Strategic Location on Supply Chain Efficiency
Pharma
Jan 08, 2025

Impact of Strategic Location on Supply Chain Efficiency

Pharmaceutical companies face increasingly complex supply chains, making strategic partnerships with third-party logistics providers like Frontier Scientific Solutions essential.

Screening T7 Polymerases to Optimize xRNA Yield and Quality
RNA
Jan 07, 2025

Screening T7 Polymerases to Optimize xRNA Yield and Quality

ReciBioPharm is advancing RNA development and manufacturing by combining a robust knowledge library and advanced screening techniques to identify the optimal T7 polymerase for each xRNA construct.

Economic and Environmental Benefits of Utilizing a Foreign Trade Zone
Foreign Trade
Jan 02, 2025

Economic and Environmental Benefits of Utilizing a Foreign Trade Zone

Foreign Trade Zones like Frontier Scientific Solutions’ operations in Wilmington provide cost-saving opportunities through duty deferral, optimize the movement of goods, and reduce the need for long-distance transport.

Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Sustainability
Jan 02, 2025

Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive

Pharma’s Almanac’s Sophie Lutter, Ph.D., explores the progress to date and the challenges ahead as pharma reckons with plastic waste and the industry’s sustainability goals.

Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
Gene
Jan 07, 2025

Synthetic DNA Delivers a Sustainable Future for Genetic Medicines

As advanced therapies grow, Touchlight's enzymatic dbDNA technology exemplifies a sustainable shift from traditional plasmid DNA production methods, addressing high costs, scalability challenges, and environmental impacts.

Enabling Digital Twins With Computational Fluid Dynamics Modeling
Biomanufacturing
Jan 15, 2025

Enabling Digital Twins With Computational Fluid Dynamics Modeling

Harnessing digital twin and computational fluid dynamics modeling technology, Samsung Biologics optimizes process development, streamlines technology transfers, and evaluates process changes and scale-up manufacturing operations.

AI Implementation to Enhance Quality
AI
Dec 13, 2024

AI Implementation to Enhance Quality

Samsung Biologics’ approach to AI demonstrates how the technology enhances these areas to drive innovation and continuously align with best practices.

Oncolytic Virotherapy: Real Potential and Difficult Challenges
Virotherapy
Dec 02, 2024

Oncolytic Virotherapy: Real Potential and Difficult Challenges

oncolytic-virotherapy-real-potential-and-difficult-challenges

Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA
Nonviral Delivery
Dec 16, 2024

Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA

Touchlight’s Lisa Caproni, Ph.D., explains how dbDNA offers the potential to unlock new therapeutic possibilities in nonviral gene delivery.

Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Autoimmune Diseases
Dec 11, 2024

Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities

Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities

Recommended

NorthX Biologics Appoints Patrick DePalma Senior Vice President of North American Business Development
Announcement
Jan 20, 2025
NorthX Biologics Appoints Patrick DePalma Senior Vice President of North American Business Development
Caris Life Sciences Strategically Collaborates with Ontada to Advance Oncology Research and the Adoption of Precision Medicine
Announcement
Jan 20, 2025
Caris Life Sciences Strategically Collaborates with Ontada to Advance Oncology Research and the Adoption of Precision Medicine
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a Market Projected to Grow to USD$48,000,000,000 by 2030
DPX
Jan 17, 2025
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a Market Projected to Grow to USD$48,000,000,000 by 2030

Spotlight

Samsung Biologics Hosts ESG Event with Suppliers to Strengthen Decarbonization Efforts
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
PCI Pharma Services Wins Supply Chain Excellence Award for Digital Platform to Manage Clinical Trials and Commercial Lifespans
Vetter Strengthens Senior Management Team for Further Sustainable Growth
Frontier Scientific Solutions Unveils Plans for a Trade Zone Gateway Dedicated for Life Sciences Supply Chain
GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research
ad image

Featured Content

featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
ad image

Nice Insights

Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing
Cell-Free
Feb 14, 2024
Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
Synthetic DNA
Feb 06, 2024
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
Why Life Science Companies Surged amid a Global M&A Downturn
Financing
Oct 15, 2024
Why Life Science Companies Surged amid a Global M&A Downturn
Biotech Training is a Challenge
Training
Jun 11, 2024
Biotech Training is a Challenge
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Sustainability
Jan 02, 2025
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Genomics
Jan 30, 2024
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
Outsourced Manufacturing
Mar 27, 2024
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
PROTACS: Upgrading Small Molecule Inhibitors
Protein Degradation
Jun 11, 2024
PROTACS: Upgrading Small Molecule Inhibitors
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Virotherapy
Dec 02, 2024
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Biotech Funding Ups and Downs
Nice Insight Reports
Apr 02, 2024
Biotech Funding Ups and Downs
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Exosomes
May 09, 2024
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Drug Delivery
Aug 30, 2024
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
ad image

Top 5

#1

CDMO

Advancing the Science of Technical and Therapeutic Proteins
#2
#3
#4
#5
ad image

Roundtable

View all roundtable
ad image

Editor's Picks

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
AAV Quality
Dec 02, 2024
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Bispecifics
Sep 27, 2024
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Designing Quality into Biomanufacturing
QbD
Oct 29, 2024
Designing Quality into Biomanufacturing
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
dbDNA
Aug 19, 2024
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Autoimmune Diseases
Dec 11, 2024
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
A New Vision for Progressing Advanced Therapies
Advanced Therapies
Oct 25, 2024
A New Vision for Progressing Advanced Therapies
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Biomanufacturing
Nov 11, 2024
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Building the Future of E. coli Biomanufacturing with Protein Secretion
Technology
Nov 18, 2024
Building the Future of E. coli Biomanufacturing with Protein Secretion
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Virotherapy
Dec 02, 2024
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Exosomes
May 09, 2024
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Gene Editing
Sep 30, 2024
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Sustainability
Jan 02, 2025
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
ad image

Videos

View all videos
Terpenes
Nov 12, 2024

Primal Organix's Nutraceutical Approach to Better Mental Health

Frank Giampieri, CEO and Founder of Primal Organix, discusses his company’s mission to promote mental health and well-being through their nutraceutical products made with terpenes — naturally occurring organic compounds found in plant oils

Primal Organix's Nutraceutical Approach to Better Mental Health
Terpenes
Nov 12, 2024
Primal Organix's Nutraceutical Approach to Better Mental Health
QBI is Helping Translate Brain Research into Treatments
Neuroscience
Nov 15, 2024
QBI is Helping Translate Brain Research into Treatments
Shining Light on the Communicable Disease Plight in Australia's Koalas
Koalas
Nov 15, 2024
Shining Light on the Communicable Disease Plight in Australia's Koalas
Better Outcomes for Cancer Patients Begin with Screening
Diagnostics
Nov 15, 2024
Better Outcomes for Cancer Patients Begin with Screening
Exploring the Microbiome with Servatus
LBPs
Nov 18, 2024
Exploring the Microbiome with Servatus
Leaps and Bounds for Synthetic Biology Startups
Synthetic Biology
Nov 15, 2024
Leaps and Bounds for Synthetic Biology Startups
Advancing Personalized Medicines and Precision Therapeutics
Precision Medicine
Nov 15, 2024
Advancing Personalized Medicines and Precision Therapeutics
Translating Academic Pursuits into Real-World Applications
Research
Nov 15, 2024
Translating Academic Pursuits into Real-World Applications
Building on Australia's Existing Biopharma Infrastructure
Biotherapeutics
Nov 15, 2024
Building on Australia's Existing Biopharma Infrastructure
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Bioassays
Nov 12, 2024
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Synthetic Biology
Nov 15, 2024
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Navigating the Australian Clinical Trials Landscape
Commissioning
Nov 15, 2024
Navigating the Australian Clinical Trials Landscape

Latest

View all latest
Biomanufacturing
Jan 15, 2025
Enabling Digital Twins With Computational Fluid Dynamics Modeling
Pharma
Jan 08, 2025
Impact of Strategic Location on Supply Chain Efficiency
Gene
Jan 07, 2025
Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
RNA
Jan 07, 2025
Screening T7 Polymerases to Optimize xRNA Yield and Quality
Foreign Trade
Jan 02, 2025
Economic and Environmental Benefits of Utilizing a Foreign Trade Zone
Large Molecule
Jan 02, 2025
Managing Pharmacovigilance Challenges for Biosimilars
Sustainability
Jan 02, 2025
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
CDMO
Jan 02, 2025
Navigating the Complexities of Microbial and Mammalian Manufacturing
ad image
ad image
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE

Subscribe for the Newsletter

Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.

The Road To Series

030db6fe-32bf-4364-88b0-28655c88acf9
ea932e33-29ac-48c3-9e59-fea0994b10cc
cfe49a93-d81b-451e-9e07-8ba4ebfc53b8
8887a25b-41b6-430d-8d52-9722c7334914
2c58207c-1481-4629-bd23-de0d0815f2b1
e6bf6f4c-ce04-4ec3-9aa9-6c34b1c2494f